Primaquine Phosphate

磷酸伯氨喹

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NamePrimaquine Phosphate
Drug Alias Name磷酸伯氨喹啉PrimaquinumPrimaquina磷酸普奈马喹Primaquine +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyeloperoxidase inhibitors
TargetsMyeloperoxidase
Therapy Area/IndicationsObesityGlucosephosphate Dehydrogenase DeficiencyMalaria, Vivax +[5] 
Global Approved IndicationsMalaria
Approved Indications in ChinaMalaria
Original Approved Country/TerritoryN/A
Original Approved Date1950/01/01
Country/TerritoryUnited StatesVietnamUganda +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofiThe University Of MississippiMenzies School Of Health Research +[5] 
Inactive CompaniesUniversity Of California San FranciscoUniversity Of OxfordLondon School Of Hygiene And Tropical Medicine
Active IndicationsGlucosephosphate Dehydrogenase DeficiencyMalaria
Inactive IndicationsObesityMalaria, VivaxMalaria, Falciparum

Other Information

ATC CodeP01BA03
Related LinksWikipediaDrugBankKEGG